Drug intelligence / Profile preview

1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is an experimental small molecule belonging to the class of organic compounds known as naphthalenes, which contain a naphthalene moiety fused with a pyrazolo[3,4-d]pyrimidine core. It has not been approved for any medical use and is not currently in clinical trials. The only identified biological target is the phosphatidylinositol 4,5-bisphosphate 3‑kinase catalytic subunit gamma isoform (PIK3CG), but its pharmacological action remains unknown. There are no reported indications or marketed formulations for this compound[1].

Other names: 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Targets

PIK3CG (Phosphatidylinositol 4,5-bisphosphate 3-kinase gamma)

Beyond the preview

Go deeper on 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine.

Explore the full profile